GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » MedEquities Realty Trust Inc (NYSE:MRT) » Definitions » Peter Lynch Fair Value

MedEquities Realty Trust (MedEquities Realty Trust) Peter Lynch Fair Value : N/A (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is MedEquities Realty Trust Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for MedEquities Realty Trust's Peter Lynch Fair Value or its related term are showing as below:



MRT's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the REITs industry.
Industry Median: 1.21
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


MedEquities Realty Trust Peter Lynch Fair Value Historical Data

The historical data trend for MedEquities Realty Trust's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedEquities Realty Trust Peter Lynch Fair Value Chart

MedEquities Realty Trust Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18
Peter Lynch Fair Value
- - - - -

MedEquities Realty Trust Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MedEquities Realty Trust's Peter Lynch Fair Value

For the REIT - Healthcare Facilities subindustry, MedEquities Realty Trust's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedEquities Realty Trust's Price-to-Peter-Lynch-Fair-Value Distribution in the REITs Industry

For the REITs industry and Real Estate sector, MedEquities Realty Trust's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where MedEquities Realty Trust's Price-to-Peter-Lynch-Fair-Value falls into.



MedEquities Realty Trust Peter Lynch Fair Value Calculation

MedEquities Realty Trust's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0.17
=N/A

MedEquities Realty Trust's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $0.17.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


MedEquities Realty Trust  (NYSE:MRT) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

MedEquities Realty Trust's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=11.03/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedEquities Realty Trust Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of MedEquities Realty Trust's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MedEquities Realty Trust (MedEquities Realty Trust) Business Description

Traded in Other Exchanges
N/A
Address
3100 West End Avenue, Suite 1000, Nashville, TN, USA, 37203
MedEquities Realty Trust Inc is a self-managed and self-administered company that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The company owns, acquires, and finances healthcare-related properties. It focuses on investing in various types of properties such as acute care hospitals, skilled nursing facilities, short-stay surgical and specialty hospitals, physician clinics, diagnostic facilities, outpatient surgery centers and others. Geographically, firm has its presence in the states of Texas, California and South Carolina.
Executives
Steven I Geringer director C/O AMSURG CORP, 20 BURTON HILLS BLVD STE 500, NASHVILLE TN 37215
David L Travis officer: SVP and CAO C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
Randy L Churchey director 999 SOUTH SHADY GROVE ROAD, SUITE 600, MEMPHIS TN 38120
Todd Mansfield director 3102 WEST END AVENUE,, SUITE 400, NASHVILLE TN 37203
John N Foy director 2030 HAMILTON PLACE BLVD, STE 500, CHAGGANOOGA TN 37421-6000
Bluemountain Capital Management, Llc director 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Stuart C Mcwhorter director 113 SEABOARD LANE, FRANKLIN TN 37067
Bluemountain Gp Holdings, Llc 10 percent owner 280 PARK AVENUE,, 12TH FLOOR, NEW YORK NY 10017
Blue Mountain Credit Alternatives Master Fund L.p. 10 percent owner C/O BLUEMOUNTAIN CAPITAL MANAGEMENT, LLC, 280 PARK AVENUE, 5TH FLOOR EAST, NEW YORK NY 10017
Blue Mountain Ca Master Fund Gp, Ltd. 10 percent owner C/O BLUEMOUNTAIN CAPITAL MANAGEMENT, LLC, 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Bluemountain Long/short Credit Gp, Llc 10 percent owner 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Bluemountain Montenvers Master Fund Sca Sicav-sif 10 percent owner 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Bluemountain Montenvers Gp S.a.r.l. 10 percent owner 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Bluemountain Guadalupe Peak Fund L.p. 10 percent owner 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017
Bluemountain Strategic Credit Gp, Llc 10 percent owner 280 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10017

MedEquities Realty Trust (MedEquities Realty Trust) Headlines

From GuruFocus

MedEquities Realty Trust Board Outlines Dividend Policy

By PRNewswire PRNewswire 11-16-2018